PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-82.06%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-66.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-123.40%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-123.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-139.08%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-140.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-142.11%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.85%
Share count expansion well above LBL.AX's 2.48%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.12%
Reduced diluted shares while LBL.AX is at 2.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
129.64%
Positive OCF growth while LBL.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
120.13%
Positive FCF growth while LBL.AX is negative. John Neff would see a strong competitive edge in net cash generation.
142.30%
10Y revenue/share CAGR at 50-75% of LBL.AX's 228.01%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-24.58%
Negative 5Y CAGR while LBL.AX stands at 46.12%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
13.36%
3Y revenue/share CAGR at 50-75% of LBL.AX's 25.81%. Martin Whitman would question if the firm lags behind competitor innovations.
657.42%
10Y OCF/share CAGR above 1.5x LBL.AX's 45.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
333.39%
5Y OCF/share CAGR above 1.5x LBL.AX's 30.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
565.52%
Positive 3Y OCF/share CAGR while LBL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
-650.00%
Negative 10Y net income/share CAGR while LBL.AX is at 196.67%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-287.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-475.00%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
4382.33%
10Y equity/share CAGR above 1.5x LBL.AX's 359.09%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
132.10%
5Y equity/share CAGR at 50-75% of LBL.AX's 188.95%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
73.11%
3Y equity/share CAGR above 1.5x LBL.AX's 29.77%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while LBL.AX invests at 31.44%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-41.70%
Firm’s AR is declining while LBL.AX shows 32.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.93%
Inventory growth well above LBL.AX's 6.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-9.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-11.60%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-63.18%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.16%
We cut SG&A while LBL.AX invests at 28.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.